ALBUTROPIN
Dead / Abandoned — Abandoned — no statement of use filed (as of 05 Sept 2016)
What this means for you
This application is over — abandoned 05 Sept 2016. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85826006
- Mark type
- Stylized text
- Filed
- 17 Jan 2013
- Published for opposition
- 04 Jun 2013
- Abandoned
- 05 Sept 2016
- Attorney of record
- Angela L. Wilson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, fusion protein for treatment of growth hormone deficiency
Owner
- GLAXOSMITHKLINE INTELLECTUAL PROPERTY LIMITED, BRENTFORD MIDDLESEX, GB
- Human Genome Sciences, Inc., Rockville, MD, US
- Human Genome Sciences, Inc., Rockville, MD, US
Prosecution history
- 06 Sept 2016 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 05 Sept 2016 — ABANDONMENT - NO USE STATEMENT FILED
- 02 Feb 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jan 2016 — SOU EXTENSION 5 GRANTED
- 25 Jan 2016 — SOU EXTENSION 5 FILED
- 25 Jan 2016 — SOU TEAS EXTENSION RECEIVED
- 23 Jul 2015 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jul 2015 — SOU EXTENSION 4 GRANTED
- 13 Jul 2015 — SOU EXTENSION 4 FILED
- 13 Jul 2015 — SOU TEAS EXTENSION RECEIVED
- 09 Jun 2015 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Feb 2015 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Feb 2015 — SOU EXTENSION 3 GRANTED
- 27 Jan 2015 — SOU EXTENSION 3 FILED
- 27 Jan 2015 — SOU TEAS EXTENSION RECEIVED